复发胶质母细胞瘤患者术前MRI强化特征对术后复发时间的预测价值

doi:10.3969/j.issn.1672-6731.2019.12.008

中国现代神经疾病杂志 ›› 2019, Vol. 19 ›› Issue (12): 954-957. doi: 10.3969/j.issn.1672-6731.2019.12.008

2 复发胶质母细胞瘤患者术前MRI强化特征对术后复发时间的预测价值

宋昆¹, 秦智勇¹, 徐浩¹, 邱天明¹, 程爱兰², 初曙光²

1. 200040 上海, 复旦大学附属华山医院神经外科;
2. 200120 上海, 同济大学附属东方医院医学影像科

收稿日期:2019-12-19 出版日期:2019-12-25 发布日期:2020-01-03
通讯作者: 初曙光,Email:chushu1018@hotmail.com

Predictive value of preoperative MRI enhancement features on postoperative recurrent time in recurrent glioblastoma patients

SONG Kun¹, QIN Zhi-yong¹, XU Hao¹, QIU Tian-ming¹, CHENG Ai-lan², CHU Shu-guang²

1. epartment of Neurosurgery, Huashan Hospital, Fudan University, Shanghai 200040, China;
2. Department of Radiology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China SONG Kun and QIN Zhi-yong contributed equally to the article

Received:2019-12-19 Online:2019-12-25 Published:2020-01-03
Contact: CHU Shu-guang (Email:chushu1018@hotmail.com)

摘要/Abstract

摘要：

目的分析胶质母细胞瘤患者术前MRI强化特征与术后复发时间的关系，探讨影像学征象对术后复发时间的预测价值。方法收集2012年2月至2017年4月经组织病理证实的36例胶质母细胞瘤患者手术前后T₁WI平扫和增强扫描资料，手动测量增强MRI图像上病灶强化区和无强化坏死区体积，根据坏死区所占整个瘤体体积百分比进行结构测量（A组坏死区所占比例 > 50%，B组实性区所占比例 > 50%），分析两组患者术前MRI强化特征、术后首次复发时间、MRI表现及总生存期的特点。结果 A组患者术后复发时间短于B组患者[（6.00 ±0.99）个月对（9.00 ±1.49）个月，P=0.049]，以坏死类型为主的胶质母细胞瘤患者术后复发时间更早。基于临床特征对A组和B组患者进行分层，在年龄<65岁、接受放化疗分层中，A组患者复发时间仍短于B组患者[6（3，8）个月对9（6，13）个月、6（6，10）个月对12（3，24）个月，均P<0.05]。结论术前增强MRI病灶类型和表现，对年龄 < 65岁、接受放化疗的胶质母细胞瘤患者的术后复发时间具有预测价值。

关键词: 胶质母细胞瘤, 复发, 磁共振成像

Abstract:

Objective To analyze the relationship between preoperative enhanced MRI manifestation and recurrent time of recurrent glioblastoma, and to explore the predictive value of imaging signs for recurrence time. Methods A total of 36 patients with pathologically confirmed glioblastoma were collected from February 2012 to April 2017. All patients underwent preoperative and postoperative T₁WI and enhanced MRI scans, and enhanced cross-sections and sagittal or coronary scans were performed. Manually measure the volume of the lesion-enhanced and non-enhanced necrotic areas on the enhanced MRI image. The totality was divided into 2 groups according to the percentage of necrosis that accounts for the entire tumor volume. Necrosis in group A accounts for > 50% of the total tumor volume, and necrosis in group B accounts for < 50% of the total tumor volume. Analyze the enhanced MRI features before surgery, the time of first recurrence, MRI manifestations and overall survival (OS). Results The recurrence time in group A was significantly shorter than that in group B[(6.00 ±0.99) months vs. (9.00 ±1.49) months, P=0.049]. Necrotic-based glioblastomas recurred faster. When stratifying patients in group A and group B based on clinical characteristics, the recurrence time of patients in group A was still significantly shorter than that in group B in the group of age < 65 years old and receiving radiotherapy and chemotherapy[6 (3, 8) months vs. 9 (6, 13) months, 6 (6, 10) months vs. 12 (3, 24) months; P<0.05, for all]. Conclusions Preoperative enhanced MRI findings have predictive value for postoperative recurrence in patients with glioblastoma who are younger than 65 years old and receive radiotherapy and chemotherapy.

Key words: Glioblastoma, Recurrence, Magnetic resonance imaging

宋昆, 秦智勇, 徐浩, 邱天明, 程爱兰, 初曙光. 复发胶质母细胞瘤患者术前MRI强化特征对术后复发时间的预测价值[J]. 中国现代神经疾病杂志, 2019, 19(12): 954-957.

SONG Kun, QIN Zhi-yong, XU Hao, QIU Tian-ming, CHENG Ai-lan, CHU Shu-guang. Predictive value of preoperative MRI enhancement features on postoperative recurrent time in recurrent glioblastoma patients[J]. Chinese Journal of Contemporary Neurology and Neurosurgery, 2019, 19(12): 954-957.

http://journal11.magtechjournal.com/cjcnn/CN/Y2019/V19/I12/954

参考文献

[1] Malzkorn B, Reifenberger G. Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors[J]. Pathologe, 2019, 40:9-17.
[2] Marko NF, Weil RJ, Schroeder JL, Lang FF, Suki D, Sawaya RE. Extent of resection of glioblastoma revisited:personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery[J].J Clin Oncol, 2014, 32:774-782.
[3] Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma[J]. N Engl J Med, 2005, 352:987-996.
[4] Weller M, Cloughesy T, Perry JR, Wick W. Standards of care for treatment of recurrent glioblastoma:are we there yet[J]? Neuro Oncol, 2013, 15:4-27.
[5] Harrison RA, de Groot JF. Treatment of glioblastoma in the Elderly[J]. Drugs Aging, 2018, 35:707-718.
[6] Sui ZY, Li GW, Zhao B. Differential diagnosis of MRI between recurrent glioma and radiation brain injury[J]. Zhongguo Shi Yong Yi Kan, 2018, 45:27-29.[睢争妍, 李国文, 赵兵. 胶质瘤复发与放射性脑损伤的MRI鉴别诊断[J]. 中国实用医刊, 2018, 45:27-29.]
[7] Li ZC, Bai H, Sun Q, Zhao Y, Lv Y, Zhou J, Liang C, Chen Y, Liang D, Zheng H. Multiregional radiomics profiling from multiparametric MRI:identifying an imaging predictor of IDH1 mutation status in glioblastoma[J]. Cancer Med, 2018, 7:5999-6009.
[8] Park YW, Choi YS, Ahn SS, Chang JH, Kim SH, Lee SK. Radiomics MRI phenotyping with machine learning to predict the grade of lower-grade gliomas:a study focused on nonenhancing tumors[J]. Korean J Radiol, 2019, 20:1381-1389.
[9] Li X, Liao S, Hua J, Guo L, Wang D, Xiao X, Zhou J, Liu X, Tan Y, Lu L, Xu Y, Wu Y. Association of glioma grading with inflow-based vascular-space-occupancy MRI:a preliminary study at 3T[J]. J Magn Reson Imaging, 2019, 50:1817-1823.
[10] Wang YL, Chen S, Xiao HF, Li Y, Wang Y, Liu G, Lou X, Ma L. Differentiation between radiation-induced brain injury and glioma recurrence using 3D pCASL and dynamic susceptibility contrast-enhanced perfusion-weighted imaging[J]. Radiother Oncol, 2018, 129:68-74.
[11] Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S. Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging[J]. Radiology, 2009, 253:486-496.
[12] Bisdas S, Naegele T, Ritz R, Dimostheni A, Pfannenberg C, Reimold M, Koh TS, Ernemann U. Distinguishing recurrent high-grade gliomas from radiation injury:a pilot study using dynamic contrast-enhanced MR imaging[J]. Acad Radiol, 2011, 18:575-583.
[13] Xu JL, Li YL, Lian JM, Dou SW, Yan FS, Wu H, Shi DP. Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging[J]. Neuroradiology, 2010, 52:1193-1199.
[14] Rogers LR, Gutierrez J, Scarpace L, Schultz L, Ryu S, Lord B, Movsas B, Honsowetz J, Jain R. Morphologic magnetic resonance imaging features of therapy-induced cerebral necrosis[J]. J Neurooncol, 2011, 101:25-32.

[1]	任修德, 李涛, 范吉康, 王希森, 贾晓丹, 杨学军. 胶质母细胞瘤FGFR3-TACC3融合基因介导丙酮酸激酶M2入核促进DNA损伤修复基础研究[J]. 中国现代神经疾病杂志, 2023, 23(8): 745-757.
[2]	潘希娟, 邢英琦, 刘玉梅. 脑小血管病影像学评分方法[J]. 中国现代神经疾病杂志, 2023, 23(7): 633-637.
[3]	邵暇荔, 张泳, 金莉蓉, 王剑. 震颤为主型帕金森病与特发性震颤患者脑灌注对比分析[J]. 中国现代神经疾病杂志, 2023, 23(6): 542-548.
[4]	刘智强, 陈金桃, 唐文龙, 翁超群, 张金锋, 林志雄. Dandy-Walker综合征患儿腹腔分流术前后临床与影像学特征分析[J]. 中国现代神经疾病杂志, 2023, 23(5): 433-438.
[5]	姚莉萍, 王睿晗, 包翌, 蔡瀚林, 陈芹. 后部皮质萎缩临床及影像学特征分析[J]. 中国现代神经疾病杂志, 2023, 23(4): 326-334.
[6]	葛懿, 陈聪, 王爽, 丁瑶. 7T超高场强MRI在耐药性癫痫诊断与治疗中的应用进展[J]. 中国现代神经疾病杂志, 2023, 23(3): 161-166.
[7]	耿雨梅, 李存, 李慧敏, 王梦莹, 康慧聪. 伴癫痫发作的自身免疫性脑炎临床特征分析[J]. 中国现代神经疾病杂志, 2023, 23(3): 205-213.
[8]	刘敏婷, 戴利军, 张振斌, 邵媛, 赖名耀, 张笑坛. 转化生长因子-β联合CD3⁺、CD4⁺、CD8⁺T细胞检测胶质母细胞瘤免疫微环境初探[J]. 中国现代神经疾病杂志, 2023, 23(3): 247-253.
[9]	李建瑞, 刘宵雪, 许强, 骆仲强, 卢光明, 张志强. 扩散峰度成像直方图联合EphA2分级在胶质瘤分级诊断中的价值[J]. 中国现代神经疾病杂志, 2023, 23(3): 254-263.
[10]	孙梦凡, 姜季委, 王艳丽, 张源, 徐俊. 动脉自旋标记测定脑血流量在阿尔茨海默病研究中的进展[J]. 中国现代神经疾病杂志, 2023, 23(1): 29-34.
[11]	于宁波, 游煜根, 王鸿鹏, 秦岩丁, 梁思泉, 韩建达. 机器人辅助神经介入手术研究进展[J]. 中国现代神经疾病杂志, 2023, 23(1): 45-52.
[12]	李佩湖, 封浑, 李吕力, 姜炳坚. 以脑卒中样发病的可逆性胼胝体压部病变综合征Ⅱ型二例[J]. 中国现代神经疾病杂志, 2022, 22(9): 817-822.
[13]	姚庆宇, 马龙冰, 菅凤增. 脊髓空洞症大鼠模型长期稳定性评价[J]. 中国现代神经疾病杂志, 2022, 22(8): 662-668.
[14]	沈东超, 邹鹏, 侯波, 杨洵哲, 刘明生, 崔丽英. 肢体发病与延髓发病的肌萎缩侧索硬化症患者脑灰质结构成像对比研究[J]. 中国现代神经疾病杂志, 2022, 22(7): 601-607.
[15]	刘子悦, 朱以诚. 脑小静脉与脑结构变化相关研究进展[J]. 中国现代神经疾病杂志, 2022, 22(6): 450-454.

选择文件类型/文献管理软件名称

选择包含的内容

2 复发胶质母细胞瘤患者术前MRI强化特征对术后复发时间的预测价值

Predictive value of preoperative MRI enhancement features on postoperative recurrent time in recurrent glioblastoma patients

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

2 复发胶质母细胞瘤患者术前MRI强化特征对术后复发时间的预测价值

Predictive value of preoperative MRI enhancement features on postoperative recurrent time in recurrent glioblastoma patients

RichHTML

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价